"Hemolysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Descriptor ID |
D006461
|
| MeSH Number(s) |
C23.550.403 G12.122.545
|
| Concept/Terms |
Extravascular Hemolysis- Extravascular Hemolysis
- Extravascular Hemolyses
- Hemolyses, Extravascular
- Hemolysis, Extravascular
Intravascular Hemolysis- Intravascular Hemolysis
- Hemolyses, Intravascular
- Hemolysis, Intravascular
- Intravascular Hemolyses
|
Below are MeSH descriptors whose meaning is more general than "Hemolysis".
Below are MeSH descriptors whose meaning is more specific than "Hemolysis".
This graph shows the total number of publications written about "Hemolysis" by people in this website by year, and whether "Hemolysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1997 | 1 | 1 | 2 |
| 1999 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 2 | 2 |
| 2014 | 1 | 1 | 2 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 2 | 3 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemolysis" by people in Profiles.
-
Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11?years. Pediatr Blood Cancer. 2022 08; 69(8):e29716.
-
SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems. Front Immunol. 2021; 12:767347.
-
Facial Amphiphilicity-Induced Polymer Nanostructures for Antimicrobial Applications. ACS Appl Mater Interfaces. 2020 May 13; 12(19):21221-21230.
-
In Vitro Thrombogenicity Testing of Biomaterials. Adv Healthc Mater. 2019 11; 8(21):e1900527.
-
Diagnosis of Hemoglobin M Disease in a Toddler Presenting With Hypoxemia and Hemolysis. Clin Pediatr (Phila). 2019 10; 58(11-12):1345-1348.
-
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.
-
Charged Metallopolymer-Grafted Silica Nanoparticles for Antimicrobial Applications. Biomacromolecules. 2018 02 12; 19(2):417-425.
-
New Application of Neomycin B-Bisbenzimidazole Hybrids as Antifungal Agents. ACS Infect Dis. 2018 02 09; 4(2):196-207.
-
Sickle cell disease. Lancet. 2017 07 15; 390(10091):311-323.
-
Small-molecule suppression of ?-lactam resistance in multidrug-resistant gram-negative pathogens. J Med Chem. 2014 Sep 11; 57(17):7450-8.